Clinical Trials Directory

Trials / Completed

CompletedNCT03093142

The Treatment Effectiveness of Combined tDCs and Neurofeedback (NF) for Patients With Cognitive Deficits After Stroke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Kowloon Hospital, Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a double blinded, randomized control trial with a pretest-posttest control and interventional groups design. Both the assessor and participants are blinded to all assessments and evaluations. All patients with subacute stroke undergo in-patient or out-patient rehabilitation are screened initially by a series of screening test. Suitable patients are assigned randomly to 3 groups respectively. Group 1 is the combined transcranial direct current stimulation (tDCS) and neurofeedback group. Group 2 is the neurofeedback group. Group 3 is the control group with sham neurofeedback training.

Detailed description

Treatment sessions for all three groups are conducted by the investigators who has training in neurofeedback and transcranial direct current stimulation (tDCs). Each participant performed 10 training sessions on different days. Sessions were conducted 3-5 times a week The tDCS + neurofeedback group will carry out 30 minutes tDCS and 30 minutes neurofeedback training. The real neurofeedback group will carry out 30 minutes neurofeedback training. The sham neurofeedback group will conduct the 30 minutes sham neurofeedback training.

Conditions

Interventions

TypeNameDescription
DEVICEtDCS & neurofeedbacktDCs and neurofeedback
DEVICEneurofeedbackNeurofeedback
DEVICEsham neurofeedbacksham neurofeedback

Timeline

Start date
2017-03-01
Primary completion
2020-12-30
Completion
2020-12-30
First posted
2017-03-28
Last updated
2024-03-06

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03093142. Inclusion in this directory is not an endorsement.